CEVA Logistics has launched FORPATIENTS healthcare logistics sub-brand, a patient-centric focus for healthcare logistics solutions, including for COVID-19 vaccines.
The new sub-brand aims to support better patient outcomes through the company’s range of healthcare logistics services. CEVA FORPATIENTS will offer healthcare and pharmaceutical companies end-to-end logistics solutions aiming to place the patient at the centre of the supply chain. As part of the solutions, the company is also introducing a new temperature-sensitive logistics product that will begin service in the second quarter of 2021.
The CEVA FORPATIENTS now encompasses temperature-sensitive solutions, pharma and biopharma, medical devices, consumer health, hospital and home care, as well as diagnostic and laboratory services. Centralising its global healthcare offerings under the FORPATIENTS umbrella aims to give greater visibility of CEVA Logistics’ services.
CEVA’s healthcare solutions intend to address quality, privacy and compliance requirements, including being fully GxP and GDP compliant and meeting all national and international regulatory requirements.
The new CEVA Logistics’ solution requires investment in temperature-controlled facilities around the world. With the support of its parent company, the CMA CGM Group, CEVA has committed to operating a network of more than 40 such airfreight stations by the end of 2021. Some of the stations will also offer other services, such as contract logistics support. This is said to allow CEVA Logistics to supply more than 1,450 healthcare trade lanes globally.
As part of its product offerings, CEVA will provide visibility and monitoring solutions for real-time decisions through embedded location and temperature IoT devices. Information will flow into the company’s award-winning Matrix® supply chain management tool, as well as its global control tower technology for 24/7 shipment monitoring, according to the company. This multi-layered approach hopes to ensure shipments are maintained at required temperatures. With vaccine and medicine transport growing globally, CEVA will focus its efforts on the 2- to 8-degree Celsius spectrum of products, including certain COVID-19 vaccines, requiring lower temperatures throughout transport.
In addition, CEVA’s approach is stated to include lane risk assessment, performance and capability management as well as a fully integrated cold chain transportation and storage management solution. The company also provides insight on the sustainability and carbon impact of various routing, packaging and mode of transport choices.
Niels Van Namen, executive vice president of CEVA’s Global Healthcare Sector, said, “Our customers supply the vaccines, medical devices, medication and other support products on which patients around the world depend. For example, diabetic patients should not have to worry about supply chain reliability for their insulin. At CEVA, we’re expanding our temperature-sensitive solutions to ensure that, no matter the logistics challenges faced, patients’ needs are met. Behind every shipment, we see a patient.”
Mathieu Friedberg, CEO, CEVA Logistics, said, “The global healthcare market has seen enormous change over the last year as a result of the pandemic that continues to affect daily life. The pandemic is also combining with the advance of technology and at-home treatment to usher in a new era of healthcare. As an agile logistics provider, CEVA will continue to offer new healthcare logistics solutions for our customers, and ultimately their patients. Today’s new FORPATIENTS sub-brand confirms our commitment as a responsive and reliable supply chain for better patient outcomes.”
Source: CEVA Logistics